Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00958282 · ClinicalTrials.gov registry record · Phase 2
Treatment of Cocaine Dependence With Lisdexamfetamine
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
NCT00958282 is a Phase 2 study that has completed, run by University of Minnesota. The registered enrollment target is 43 participants.
The verdict
NCT00958282, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
Study Summary
This protocol is a 2-group double-blind placebo-controlled outpatient study investigating lisdexamfetamine for treatment of cocaine dependence. The investigators plan to enroll 100 subjects in a 14-week trial. The primary objectives will determine changes in cocaine use and secondary objectives will be cocaine craving and impulsivity.
Interventions
- OTHER placebo
- DRUG lisdexamfetamine/Behavior Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2009-07 |
| Est. Completion | 2013-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00958282
The ClinicalTrials.gov registry entry for NCT00958282 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00958282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00958282 about?
NCT00958282 is a clinical study titled "Treatment of Cocaine Dependence With Lisdexamfetamine". This protocol is a 2-group double-blind placebo-controlled outpatient study investigating lisdexamfetamine for treatment of cocaine dependence. The investigators plan to enroll 100 subjects in a 14-week trial. The primary objectives will determine changes in cocaine use and secondary objectives will...
What is the current status of trial NCT00958282?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2009-07. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00958282?
The interventions under investigation include: placebo (OTHER), lisdexamfetamine/Behavior Therapy (DRUG).
Who is sponsoring clinical trial NCT00958282?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.